People living in rural, remote, and frontier settings face higher colorectal cancer (CRC) incidence and mortality rates, increased prevalence of risk factors associated with CRC, and unique barriers to cancer screenings when compared to non-rural residents. Common obstacles to screening can be exacerbated by the challenges that come with living in areas that are less densely populated and more geographically isolated. Overcoming these barriers requires creativity, resilience, and flexibility.
To address this need, the ACS NCCRT developed this guidebook to support key community partners in understanding and overcoming the unique challenges and common barriers to CRC screening faced in rural communities. The guidebook features:
- Recent data and statistics illustrating the burden of CRC in rural areas
- Five recommended actions to increase CRC screening rates
- Five case studies highlighting best practices and lessons learned from geographically and demographically diverse organizations
Learn more about the guidebook by registering for our webinar on the resource!
Appendices
Acknowledgements
The ACS NCCRT would like to thank the Rural Communities Advisory Committee members, who generously offered their time and expertise to develop this guidebook’s content, and to One Health Insights for serving as the lead author.
See the Acknowledgements section for a comprehensive list of the many contributors.
Explore More

Increasing Colorectal Cancer Screening in Rural Communities: A Practical Guide
This guidebook is designed to support key community partners in understanding and overcoming the unique challenges and common barriers to CRC screening faced in rural communities.

Blue Star Conversation: July 9, 2025
This Blue Star Conversation covered the topic, "2025 Supreme Court Case Update: How Kennedy v. Braidwood Management Could Affect Insurance Coverage for CRC Screening".

Clinician’s Reference: Stool-Based Tests for Colorectal Cancer Screening
This revised resource is designed to introduce (or reintroduce) clinicians to the value of stool-based testing for colorectal cancer.